Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)

  1. Caballero Mateos, I.
  2. García de Lucas, M.D.
  3. Doulatram-Gamgaram, V.K.
  4. Moreno-Moreno, P.
  5. Jimenez-Millan, A.I.
  6. Botana-López, M.
  7. Merino-Torres, J.F.
  8. Soto-Gónzalez, A.
  9. Fernández-García, J.C.
  10. Morales-Portillo, C.
Zeitschrift:
Nutrients

ISSN: 2072-6643

Datum der Publikation: 2024

Ausgabe: 16

Nummer: 15

Art: Artikel

DOI: 10.3390/NU16152545 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus